Report : Asia Pacific Wound Care Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care, and Wound Therapy Devices), Wound Type (Chronic Wounds and Acute Wounds), and End User (Hospitals, Specialty Clinics, Home Healthcare, and Others)
At 6.4% CAGR, the Asia Pacific Wound Care Market is speculated to be worth US$ 5,776.72 million by 2028, says The Business Market Insights
According to the Business Market Insights’ research, the Asia Pacific wound care market was valued at US$ 3,974.65 million in 2022 and is expected to reach US$ 5,776.72 million by 2028, registering a CAGR of 6.4% from 2022 to 2028. Increasing cases of road traffic injuries and rising prevalence of chronic diseases and related wounds are the critical factors attributed to the Asia Pacific wound care market expansion.
The wound care market experiences various changes in the technology landscape, enabling players to develop innovative products. State-of-the-art products may assist in conferring improved health conditions. Leading companies consolidate the market through various R&D activities to offer modern products. To support market development, the governments of many countries have invested in clinical research infrastructure for wound care. Thus, the rise in product launches, approvals, collaborations, and research infrastructure is expected to offer lucrative opportunities for the Asia Pacific wound care market during the forecast period.
On the contrary, challenges in wound care management and increase in product recalls hurdles the growth of Asia Pacific wound care market.
Based on product, the Asia Pacific wound care market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment held 39.2% market share in 2022, amassing US$ 1,556.15 million. It is projected to garner US$ 2,393.30 million by 2028 to expand at 7.4% CAGR during 2022–2028.
Based on wound type, the Asia Pacific wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment held 62.1% market share in 2022, amassing US$ 2,468.69 million. It is projected to garner US$ 3,643.33 million by 2028 to expand at 6.7% CAGR during 2022–2028.
Based on end user, the Asia Pacific wound care market is segmented into hospitals, specialty clinics, home healthcare, and others. The hospitals segment held 39.7% market share in 2022, amassing US$ 1,579.33 million. It is projected to garner US$ 2,369.90 million by 2028 to expand at 7.0% CAGR during 2022–2028.
Based on country, the Asia Pacific wound care market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 28.8% market share in 2022. It was assessed at US$ 1,143.11 million in 2022 and is likely to hit US$ 1,723.20 million by 2028, exhibiting a CAGR of 7.1% during the forecast period.
Key players dominating the Asia Pacific wound care market are 3M Co, Baxter International Inc, Coloplast AS, ConvaTec Group Plc, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Medtronic Plc, MiMedx, PAUL HARTMANN AG, and Smith & Nephew Plc among others.
- In May 2021, 3M announced the launch of 3M Prevena Restor BellaForm Therapy – the next generation in post-operative healing following breast surgery.
- In July 2022, Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App. The WOUND COMPASS, Clinical Support App, is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com